Evaluation of Different Initial Doses of Envarsus in De Novo Kidney Transplant Recipients.

Consistently with the pharmacokinetic pattern, tacrolimus doses were skipped because of high trough levels in 30.8% and 27.9% of patients in groups 1 and 2, respectively, compared with 14.3% and 14.0% in groups 3 and 4, although this overall difference did not reach statistical significance ( p = 0.124).

also in 111,027 other papers

The same category showed near-significant differences for group 1 versus group 3 (p adj = 0.068) and group 2 versus group 4 (p adj = 0.055), while within-range exposure differed nominally between groups 1 and 3 (raw p = 0.018) but lost significance after correction (p adj = 0.107).

also in 2,306 other papers